Journal of Travel Medicine
Malaria chemoprophylaxis provision in the UK: a call to evaluate the cost-effectiveness and equity implications of universal provision
Kirsten Morris
1, 2
,
Hugo Turner
3, 4
,
Anna Checkley
5, 6, 7, 8
,
David Ross
9, 10
,
Peter Chiodini
11, 12
1
Defence Medical Services , Lichfield ,
2
Defence Medical Services , Whittington Barracks, Lichfield , WS14 9PY,
4
MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London , London, W12 0BZ,
7
London School of Hygiene & Tropical Medicine , Keppel St, WC1E 7HT, London ,
8
Hospital for Tropical Diseases , Mortimer Market, Capper St, WC1E 6JD, London ,
9
Royal College of Physicians and Surgeons of Glasgow, Dean, Faculty of Travel Medicine , Glasgow, Scotland ,
10
Faculty of Travel Medicine, Royal College of Physicians and Surgeons of Glasgow , Glasgow, G2 5RJ,
12
University College London Hospitals NHS Foundation Trust , London, NW1 2BU,
Publication type: Journal Article
Publication date: 2025-02-27
Journal:
Journal of Travel Medicine
scimago Q1
SJR: 1.556
CiteScore: 20.9
Impact factor: 9.1
ISSN: 11951982, 17088305
Abstract
This position paper advocates for the re-evaluation of the cost-effectiveness and equity of National Health Service (NHS)-subsidised malaria chemoprophylaxis, considering changes in UK malaria epidemiology, travel patterns, updated travel medicine guidance, novel Plasmodium falciparum treatment pathways and growing awareness and action to tackle sources of health inequities.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.